Nian Liu

704 total citations
34 papers, 551 citations indexed

About

Nian Liu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Nian Liu has authored 34 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Organic Chemistry and 9 papers in Oncology. Recurrent topics in Nian Liu's work include Melanoma and MAPK Pathways (8 papers), Quinazolinone synthesis and applications (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Nian Liu is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Quinazolinone synthesis and applications (6 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Nian Liu collaborates with scholars based in China, United States and Canada. Nian Liu's co-authors include Harriet Baker, Li Zhang, C B Underhill, Ziwei Han, Shawn J. Green, Glenn M. Swartz, Feng Gao, Grant R. Krow, Dongmei Zhao and Hao Lü and has published in prestigious journals such as Circulation, Analytical Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Nian Liu

34 papers receiving 546 citations

Peers

Countries citing papers authored by Nian Liu

Since Specialization

Citations

This map shows the geographic impact of Nian Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nian Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nian Liu more than expected).

Fields of papers citing papers by Nian Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nian Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nian Liu. The network helps show where Nian Liu may publish in the future.

Co-authorship network of co-authors of Nian Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Nian Liu. A scholar is included among the top collaborators of Nian Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nian Liu. Nian Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design, synthesis, and biological evaluation of 5-chlorine-2-amino-pyrimidine derivatives as potent PLK4 inhibitors 2025 ·RSC Medicinal Chemistry ·(unknown), Wenqiang Sun, (unknown), Minghui Tong, Xiaojun Shi, Han Wang, Nian Liu, (unknown), (unknown), Niaoqing Hu, Yixiang Sun, Haoyu Zhang, (unknown), Dongmei Zhao, Maosheng Cheng	1
2	Discovery of potent and selective PKMYT1 inhibitors for the treatment of CCNE1-amplified cancer 2025 ·European Journal of Medicinal Chemistry ·Haoyu Zhang, (unknown), Shifang Yuan, Chinyu Su, (unknown), Xudong Wu, Rui Liu, Nian Liu, Yixiang Sun, (unknown), Ting Wang, Chenzhou Hao, Yin Sun, Dongmei Zhao, Maosheng Cheng	1
3	Structure-based virtual screening discovers novel PKMYT1 inhibitors 2024 ·RSC Medicinal Chemistry ·Haoyu Zhang, (unknown), (unknown), Zhiqiang Guo, Rui Liu, (unknown), Yixiang Sun, Nian Liu, (unknown), Dongmei Zhao, Maosheng Cheng	4
4	Discovery of novel indazole derivatives as second-generation TRK inhibitors 2024 ·European Journal of Medicinal Chemistry ·(unknown), Shuyu Lu, Zhiqiang Guo, Zhuo Li, (unknown), Xin Wang, Tianxiao Wu, Yixiang Sun, Nian Liu, Haoyu Zhang, Dongmei Zhao, Maosheng Cheng	5
5	Design, synthesis and biological evaluation of novel indolin-2-one derivatives as potent second-generation TRKs inhibitors 2023 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Xin Wang, Ruicheng Lv, Shuyu Lu, Zhiqiang Guo, Tianxiao Wu, Yin Sun, Yixiang Sun, Nian Liu, Dongmei Zhao, Maosheng Cheng	7
6	Discovery of novel 3-(1H-pyrazol-4-yl)-1H-indazole derivatives as potent type II TRK inhibitors against acquired resistance 2023 ·European Journal of Medicinal Chemistry ·(unknown), Zhiqiang Guo, Shuyu Lu, Xin Wang, (unknown), Tianxiao Wu, Yixiang Sun, Nian Liu, Haoyu Zhang, Dongmei Zhao, Maosheng Cheng	4
7	Design, synthesis, and biological evaluation of novel pyrimidin-2-amine derivatives as potent PLK4 inhibitors 2023 ·RSC Medicinal Chemistry ·(unknown), (unknown), (unknown), Yin Sun, Nian Liu, Yu Sun, Lin Wang, Dongmei Zhao, Maosheng Cheng	4
8	Types of DNA damage and research progress 2023 ·Nucleosides Nucleotides & Nucleic Acids ·Nian Liu, Xiaohua Li, (unknown), (unknown)	2
9	Regulation of different protonated states of two intimate histidine residues on the reductive half-reaction of glucose oxidase 2022 ·Physical Chemistry Chemical Physics ·(unknown), (unknown), Yuxin Xie, Xin Li, Sijun Liu, Nian Liu, Xiaohua Chen	2
10	Identification and analysis of antioxidant peptides from sorghum (Sorghum bicolor L. Moench) on the basis of in vitro simulated gastrointestinal digestion 2022 ·Food & Function ·Peng Jiang, Nian Liu, (unknown), Wenhao Wang, Changyuan Wang, Dongjie Zhang, Zhijiang Li	11
11	Novel chloroquine derivative suppresses melanoma cell growth by DNA damage through increasing ROS levels 2022 ·Journal of Cellular and Molecular Medicine ·(unknown), Jing Long, Jianglin Zhang, Nian Liu, Bei Yan, (unknown), Xiang Chen, Cong Peng	2
12	Discovery of quinazoline derivatives CZw-124 as a pan-TRK inhibitor with potent anticancer effects in vitro and in vivo 2022 ·European Journal of Medicinal Chemistry ·Tianxiao Wu, (unknown), Ruicheng Lv, Nian Liu, Wenbo Yin, Chenzhou Hao, Yin Sun, Chu Zhang, Yixiang Sun, Dongmei Zhao, Maosheng Cheng	18
13	Design, synthesis and biological evaluation of pyrazolo[3,4-b]pyridine derivatives as TRK inhibitors 2022 ·RSC Medicinal Chemistry ·Nian Liu, Xin Wang, (unknown), (unknown), Tianxiao Wu, Ruicheng Lv, Dongmei Zhao, Maosheng Cheng	9
14	Design, synthesis, biological evaluation and pharmacophore model analysis of novel tetrahydropyrrolo[3,4-c]pyrazol derivatives as potential TRKs inhibitors 2021 ·European Journal of Medicinal Chemistry ·Tianxiao Wu, Chu Zhang, Ruicheng Lv, (unknown), Nian Liu, Wenbo Yin, Ruifeng Wang, Yin Sun, Xiaoyan Wang, Yixiang Sun, Dongmei Zhao, Maosheng Cheng	16
15	Improving the thermostability of trehalose synthase from Thermomonospora curvata by covalent cyclization using peptide tags and investigation of the underlying molecular mechanism 2020 ·International Journal of Biological Macromolecules ·Yao Chen, (unknown), Xue Zhou, Nian Liu, Dengming Ming, Liying Zhu, Ling Jiang	21
16	CD147 regulates melanoma metastasis via the NFAT1‐MMP‐9 pathway 2020 ·Pigment Cell & Melanoma Research ·Nian Liu, Min Qi, Keke Li, Weiqi Zeng, (unknown), Mingzhu Yin, Hong Liu, Xiang Chen, Jianglin Zhang, Cong Peng	15
17	Towards a higher-level Ensifera phylogeny inferred from mitogenome sequences 2017 ·Molecular Phylogenetics and Evolution ·Zhijun Zhou, Ling Zhao, Nian Liu, Huifang Guo, (unknown), (unknown), FU-MING SHI	49
18	Abstract 13707: Sodium Channel Blockers Prevent Triggered Activity but Not Abnormal Ca2+ Release in a Knock-in Mouse Model With Ryanodine Receptor Mutation R4496C 2010 ·Circulation ·Nian Liu, Marco Denegri, Yanfei Ruan, Tiziana Bachetti, (unknown), Carlo Napolitano, Silvia G. Priori	3
19	[T-lymphocyte voltage dependent K(+) channel is upregulated in patients with acute coronary syndrome]. 2007 ·PubMed ·(unknown), Cuntai Zhang, (unknown), Nian Liu, Liping Sun, Jun Liu, Jin Ma	1
20	Activity-dependent Nurr1 and NGFI-B gene expression in adult mouse olfactory bulb 1999 ·Neuroreport ·Nian Liu, Harriet Baker	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact